Non-alcoholic fatty liver disease concerns with glucokinase activators

Leanne Hodson, Martijn C. G. J. Brouwers*

*Corresponding author for this work

Research output: Contribution to journalComment/Letter to the editorAcademicpeer-review

6 Citations (Web of Science)
Original languageEnglish
Pages (from-to)684-685
Number of pages3
JournalThe Lancet Diabetes & Endocrinology
Issue number9
Publication statusPublished - 1 Sep 2018

Cite this